Antitumor effect of the Newcastle disease viral hemagglutinin–neuraminidase gene is expressed through an oncolytic adenovirus effect in osteosarcoma cells (English)
- New search for: Chen, Shuang
- New search for: Zhang, Qinggao
- New search for: Xu, Duo
- New search for: Li, Yiquan
- New search for: Fan, Yuanyuan
- New search for: Li, Wenjie
- New search for: Yin, Xunzhe
- New search for: Zhang, Yang
- New search for: Liu, Jingwei
- New search for: Li, Xiao
- New search for: Sun, Lili
- New search for: Jin, Ningyi
- New search for: Chen, Shuang
- New search for: Zhang, Qinggao
- New search for: Xu, Duo
- New search for: Li, Yiquan
- New search for: Fan, Yuanyuan
- New search for: Li, Wenjie
- New search for: Yin, Xunzhe
- New search for: Zhang, Yang
- New search for: Liu, Jingwei
- New search for: Li, Xiao
- New search for: Sun, Lili
- New search for: Jin, Ningyi
In:
Anti-cancer drugs
;
29
, 3
;
197-207
;
2018
-
ISSN:
- Article (Journal) / Print
-
Title:Antitumor effect of the Newcastle disease viral hemagglutinin–neuraminidase gene is expressed through an oncolytic adenovirus effect in osteosarcoma cells
-
Contributors:Chen, Shuang ( author ) / Zhang, Qinggao ( author ) / Xu, Duo ( author ) / Li, Yiquan ( author ) / Fan, Yuanyuan ( author ) / Li, Wenjie ( author ) / Yin, Xunzhe ( author ) / Zhang, Yang ( author ) / Liu, Jingwei ( author ) / Li, Xiao ( author )
-
Published in:Anti-cancer drugs ; 29, 3 ; 197-207
-
Publisher:
- New search for: Lippincott Williams and Wilkins
-
Publication date:2018-01-01
-
Size:11 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.994061
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.994061 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 29, Issue 3
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 197
-
Antitumor effect of the Newcastle disease viral hemagglutinin–neuraminidase gene is expressed through an oncolytic adenovirus effect in osteosarcoma cellsChen, Shuang / Zhang, Qinggao / Xu, Duo / Li, Yiquan / Fan, Yuanyuan / Li, Wenjie / Yin, Xunzhe / Zhang, Yang / Liu, Jingwei / Li, Xiao et al. | 2018
- 208
-
Sonic hedgehog and Wnt/β-catenin pathways mediate curcumin inhibition of breast cancer stem cellsLi, Xiaoting / Wang, Xiaoqian / Xie, Chunfeng / Zhu, Jianyun / Meng, Yu / Chen, Yue / Li, Yuan / Jiang, Ye / Yang, Xue / Wang, Shijia et al. | 2018
- 216
-
FoxM1 promotes epithelial–mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loopYang, Huiling / Wen, Li / Wen, Mingling / Liu, Tao / Zhao, Lisheng / Wu, Bo / Yun, Yuyu / Liu, Wenchao / Wang, Hao / Wang, Yu et al. | 2018
- 227
-
Sodium butyrate increases P-gp expression in lung cancer by upregulation of STAT3 and mRNA stabilization of ABCB1Zhao, Liang / Bin, Shi / He, Hong-Liang / Yang, Jing-Mo / Pu, Yue-Chen / Gao, Cai-Hong / Wang, Hao / Wang, Bao-Long et al. | 2018
- 234
-
Dioscin inhibits colon cancer cells’ growth by reactive oxygen species-mediated mitochondrial dysfunction and p38 and JNK pathwaysLi, Shu / Cheng, Binbin / Hou, Lixin / Huang, Lanwei / Cui, Yongkang / Xu, Duo / Shen, Xiaoping / Li, Shuang et al. | 2018
- 243
-
Antileukemic effects of neurokinin-1 receptor inhibition on hematologic malignant cells: a novel therapeutic potential for aprepitantBayati, Samaneh / Razani, Elham / Bashash, Davood / Safaroghli-Azar, Ava / Safa, Majid / Ghaffari, Seyed H. et al. | 2018
- 253
-
Toxicological profile and safety pharmacology of a single dose of fibroblast activation protein-α-based doxorubicin prodrug: in-vitro and in-vivo evaluationHuang, Sichao / Zhang, Yuchen / Zhong, Jinsong / Pan, Ying / Cai, Shaohui / Xu, Jun et al. | 2018
- 262
-
Antitumor effects of histone deacetylase inhibitor suberoylanilide hydroxamic acid in epidermal growth factor receptor-mutant non-small-cell lung cancer lines in vitro and in vivoWei, Ye / Zhou, Fangzheng / Lin, Zhenyu / Shi, Liangliang / Huang, Ai / Liu, Tao / Yu, Dandan / Wu, Gang et al. | 2018
- 271
-
Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancerDurairaj, Chandrasekar / Ruiz-Garcia, Ana / Gauthier, Eric R. / Huang, Xin / Lu, Dongrui R. / Hoffman, Justin T. / Finn, Richard S. / Joy, Anil A. / Ettl, Johannes / Rugo, Hope S. et al. | 2018
- 281
-
Erlotinib for coexisting typical bronchial carcinoid and advanced lung adenocarcinoma: does the epidermal growth factor receptor mutation status matter?Drpa, Gordana / Sreter, Katherina B. / Manojlovic, Spomenka / Kukulj, Suzana et al. | 2018